The SARS-CoV-2 main protease as drug target

July 5, 2020August 3, 2020 / Christoph Nitsche

ISSUE COVER_Mpro

Congratulations to Sven, who published an article in Bioorganic & Medicinal Chemistry Letters about the prospects of main protease inhibitors as antiviral agents to combat COVID-19. Our article is open access and available to everyone.

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Cancel

Connecting to %s

NITSCHE LAB

Medicinal Chemistry & Bioconjugation

The SARS-CoV-2 main protease as drug target

Leave a Reply Cancel reply

Share this:

Related

Leave a Reply Cancel reply